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Abstract
Background: Standards for the reporting of factorial randomised trials remain to be established. We aimed to
review the quality of reporting of methodological aspects of published factorial trials of complex interventions in
community settings.
Methods: We searched MEDLINE, EMBASE, PsychInfo and the Cochrane Controlled Trials Register to identify
factorial randomised trials of complex interventions in community settings from January 2000 to August 2009. We
also conducted a citation search of two review papers published in 2003. Data were extracted by two reviewers on
22 items relating to study design, analysis and presentation.
Results: We identified 5941 unique titles, from which 116 full papers were obtained and 76 were included in the
review. The included trials reflected a broad range of target conditions and types of intervention. The median
sample size was 400 (interquartile range 191-1001). Most (88%) trials employed a 2 × 2 factorial design. Few trials
(21%) explicitly stated the rationale for using a factorial design. Reporting of aspects of design, analysis or
presentation specific to factorial trials was variable, but there was no evidence that reporting of these aspects was
different for trials published before or after 2003. However, for CONSORT items that apply generally to the
reporting of all trials, there was some evidence that later studies were more likely to report employing an
intention-to-treat (ITT) approach (78% vs 52%), present appropriate between-group estimates of effect (88% vs
63%), and present standard errors or 95% confidence intervals for such estimates (78% vs 56%). Interactions
between interventions and some measure of the precision associated with such effects were reported in only 14
(18%) trials.
Conclusions: Reports of factorial trials of complex interventions in community settings vary in the amount of
information they provide regarding important methodological aspects of design and analysis. This variability
supports the extension of CONSORT guidelines to include the specific reporting of factorial trials.
Background
Factorial randomised trials offer the potential of efficient
evaluation of more than one intervention in a single
study. The design also permits investigation of interac-
tions between interventions - that is, whether the com-
bined effects are less than (antagonistic) or greater than
(synergistic) the additive effects one would observe if
the treatments acted independently of one another. The
design, analysis and reporting of factorial trials has been
described previously [1,2]. Briefly, the simplest factorial
design of two interventions involves allocating patients
to receive both, one or other, or no intervention. Analy-
sis “at the margins” assumes that the two treatments act
independently, and uses all trial participants in estimat-
ing the effects of each treatment. However “inside the
table” analysis must be used to estimate the effect of
each treatment if an interaction is suspected or
observed. As these analyses each involve only half of the
trial participants, it is easy to see why the design is most
efficient for evaluating interventions where no substan-
tive interaction is anticipated.
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vices and areas of social policy, often in community set-
tings. Evidence of effectiveness may be sought by
rigorous evaulation in randomised studies. The UK
Medical Research Council (MRC) published revised gui-
dance on developing and evaluating complex interven-
tions in 2008 [3]. It may be helpful to consider
interventions as part of a complexity continuum rather
than as a clear dichotomy between simple and complex.
The features that make an intervention complex can
include the number of interacting components, the
behaviours required by those delivering or receiving the
intervention, the groups or organisational levels tar-
geted, the number and variability of expected outcomes,
and any permitted tailoring of the intervention. Rando-
mised evaluations of complex interventions often involve
large and lengthy studies that require significant invest-
ment of time from investigators and participants, and
money from research funders. Given this investment, a
study design that enables simultaneous evaluation of
multiple interventions, or components of a complex
intervention, has an obvious attraction.
If we accept the notion of a continuum rather than a
dichotomy between simple and complex interventions, it
could be argued that most RCTs of (non-pharmacologi-
cal) health care interventions involve at least some of
the complexities listed above. In RCTs carried out in
community settings where the key perspective is a prag-
matic evaluation of effectiveness and cost-effectiveness
of interventions in as close to ‘usual’ circumstances as
possible, complex interventions are the norm. Since
community settings is where the majority of health care
is delivered internationally, and that such RCTs have
arguably the widest generalisability, it seemed timely to
focus a review on these trials. The aim of this study was
therefore to conduct a systematic review of the report-
ing of key methodological issues in published factorial
trials of complex interventions in community settings.
Methods
Data sources and search methods
We conducted searches of electronic databases in MED-
L I N E ,E m b a s ea n dP s y c h I N F Oa n dt h eC o c h r a n eC o n -
trolled Trials Register from January 2000 to August
2009. The search strategy was composed of two sets
that were combined with the AND operator. The first
set comprised Medical Subject Heading (MeSH) and
free text terms with synonyms and spelling variations to
identify randomised studies. Since there is no MeSH
term for factorial trials, the second set comprised the
free text terms “factorial”, “2b y2 ” and “2×2 ”.
Although our particular focus was trials of complex
interventions in community-based settings, reliable iden-
tification of such trials using either MeSH or free text
terms was not possible, and we were unable to include
sets for these features in the search strategy. The search
strategy excluded animal studies and was restricted to
articles published in English. We conducted citation
searches of two papers describing the design, analysis
and reporting of factorial trials both published in 2003
[1,2]. The full search strategy is given in Additional File
1.
Inclusion criteria
Studies of randomised controlled trials with factorial
designs were eligible. We defined factorial trials as those
in which more than one intervention is evaluated, and
where participants may be allocated to receive one,
more than one, or no intervention. All population
groups including adults, children and the elderly were of
interest, as were studies in which the participants were
health care professionals. The studies were restricted to
those where recruitment and treatment of participants
occurred in communities and primary care settings, and
only those where at least one of the interventions could
be considered complex as described by the UK Medical
Research Council guidance [3] were included.
Studies conducted in hospital or other secondary care
environments, and studies of interventions not consid-
ered complex were excluded. Regarding the latter, the
MRC guidance states that there is no sharp boundary
between simple and complex interventions. While exclu-
sion of some trials was clear, such as those involving
only medicinal products, others required further discus-
sion between the authors. Table 1 gives some examples
of interventions that were included/excluded. Other
exclusions were pilot studies, trial protocols, non-rando-
mised studies, secondary analyses of previously reported
trials, and studies with non-clinical primary outcomes.
Study selection and data extraction
One researcher (AAM) conducted the searches. Titles
and abstracts were screened independently by two
researchers (AAM and CE) for retrieval of full papers.
Any disagreements were resolved by consensus. We
developed a template for data extraction based on pre-
vious reviews of factorial [1] and crossover [4] trials. We
piloted the form using a random selection of five papers,
before making final modifications prior to use. We
extracted data on the reporting of important methodolo-
gical details. One reviewer extracted data (MPA) which
were then checked by a second reviewer (AAM), and
any disagreements were resolved by consensus. Authors
were contacted for further information if required.
Data analysis
Trials were categorised according to year of publication
(2000-03 versus 2004-09). These dates were selected to
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following the publication in 2003 of two papers describ-
ing the design, analysis and presentation of factorial
trials [1,2]. The proportion of trials reporting each item
was determined using simple tabulations, with differ-
ences between ‘earlier’ and ‘later’ trials investigated
using chi-squared statistics and differences in propor-
tions with 95% confidence intervals. All data were ana-
lysed using Stata 11 [5].
Results
Study selection
A total of 5941 titles were obtained from the search
strategy, from which 116 full papers were obtained for
detailed evaluation because they appeared to describe
factorial trials of complex interventions in community
settings (Figure 1). Of these, 40 were excluded, with the
most common reasons being either that the trial was
conducted in a setting other than the community, or
that none of the interventions evaluated were regarded
as complex. Of the 76 trials included, 49 (64%) were
published after 2003.
Characteristics of included trials
The studies we included encompassed a wide range of
clinical conditions, reflecting the breadth of research
based in general practice and other community settings
(Additional File 2). Most of the studies involved adult
participants (64/76, 84%). The median number of parti-
cipants was 400 (IQR 191-1001). The term “factorial”
Table 1 Examples of interventions and settings included/excluded in the review
Included Excluded
Complex intervention Simple intervention
Dietary counselling to increase fruit and vegetable consumption Dietary supplement tablets
Physiotherapy and exercise programme Specific physiotherapy technique eg manipulation,
ultrasound
Unsupervised physical exercise programme and telephone support Closely supervised strength training programme
Drug + complex intervention No complex intervention
Community setting Other setting
Primary care/general practice/family doctor/other community setting (eg home,
community centre, gym)
Hospitals/Specialist medical or research centres/
University clinics
5941 records remaining after duplicates removed. 
All titles and abstracts screened. 
116 full-text articles 
retrieved on basis of 
title and abstract 
40 full-text articles excluded: 
not community = 17 
not complex = 10 
not factorial = 5 
protocol only = 2 
secondary analysis = 2 
not randomised = 1 
pilot study = 1 
analysis of complex intervention not 
reported = 1 
not clinically relevant outcomes = 1 
76 factorial trials of complex 
interventions in community 
settings included 
72 records from 
other sources 
8178 records 
identified in 
database searches 
Figure 1 Diagram of information flow.
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(Table 2). While efficient evaluation of more than one
intervention is commonly the main reason for using a
factorial design, followed by the ability to investigate
interactions between interventions, only 16/76 (21%) of
trials explicitly stated the rationale for using this design.
Design of included trials
The majority (67/76, 88%) of trials employed a simple 2
× 2 factorial design, and randomised individuals only
(48/76, 63%) rather than clusters or a mix of individuals
and clusters. Reporting of alllocation was poor, with
only just over half (40/76, 53%) giving an adequate
description of the randomisation process, and only 31/
76 (41%) clearly describing concealment of allocation.
Of the 53/76 (70%) trials that provided a sample size
calculation, the majority (38/53, 71%) based the estimate
on analysis “at the margins”, which assumes that there
is no interaction between the interventions.
Analysis of included trials
There was some evidence that reporting of approach
to handling attrition and other breaches of protocol
was improved in trials published after 2003, with 38/
49 (78%) compared 14/27 (52%) applying the inten-
tion-to-treat (ITT) principle (risk difference = 26%,
95% CI 4% to 48%, p = 0.021). Most trials (61/76,
80%) correctly adjusted for design variables and base-
l i n ev a l u e so ft h eo u t c o m ei nt h ep r i m a r ya n a l y s e s ,
and in trials where clusters were the unit of allocation,
applied appropriate methods of analysis to allow for
this (22/28, 79%).
Nearly one third of trials (23/76, 31%) provided
neither a CONSORT diagram of participant flow nor
adequately described this in the text. In terms of asses-
sing comparability of trial arms at baseline, 12/76 (16%)
trials provided either no baseline data or presented it
for the study cohort as a whole. Of the 64/76 (84%) that
did, the majority provided baseline data “inside the
table” (46/64, 72%), with five trials (8%) providing it
both “inside the table” and “at the margins”.
Most trials (67/76, 88%) provided appropriate descrip-
tive data for the primary outcome(s) at follow up, with
similar proportions of trials reporting these data “at the
margins” (21/67, 31%), “inside the table” (26/67, 39%) or
both (20/67, 30%). There was evidence that trials pub-
lished after 2003 were more likely to provide appropri-
ate between-group estimates of effect such as differences
in means or odds ratios. Forty-three of 49 (88%) trials
published after 2003 did this compared with 17/27
(63%) of earlier studies (risk difference = 25%, 95% CI
4% to 45%, p = 0.011). Reporting of precision around
such estimates with either standard errors or 95% confi-
dence intervals was also better in later trials (38/49
(78%) versus 15/27 (56%) (risk difference = 22%, 95% CI
0% to 44%, p = 0.046).
Fifty-three trials (70%) reported the results of interac-
tion analyses, although only a minority (14/53, 26%)
providing interaction estimates and precision. The
remaining 39 trials (74%) provided either only a p-value
from the interaction analysis or a statement that no
interaction was found. All 14 (100%) trials providing
detailed results of the interaction analysis also discussed
the interaction in the discussion section of the paper,
whereas only 18/39 (46%) providing limited results of
the interaction analysis did so. Overall interpretation of
the study based on the data presented was appropriate
in nearly all trials (72/76, 95%).
Discussion
We found that reporting of design, analysis and presen-
tation issues that are specific to factorial trials was vari-
able, but there was no evidence that reporting of these
(factorial design-specific) aspects was improved for trials
published after 2003. Reporting of other important
aspects that apply generally to all trials was sometimes
inadequate, such as the process of randomisation,
including concealment, and participant flow. However,
our data suggest that reporting of certain other aspects
was improved in later trials, such as using an ITT
approach, and providing between-group estimates of
effect along with standard errors or confidence intervals.
A strength of our review is the rigorous searching of
major electronic databases to identify relevant studies.
T h ea b s e n c eo fM e S Ht e r m st or e l i a b l yi d e n t i f yt r i a l s
with factorial designs means that we may have missed
some trials that did not contain our search terms in the
text. Furthermore, although around 12% of the studies
included in our review have a design other than 2 × 2,
we cannot be certain whether this is a true reflection of
the range of factorial studies undertaken to date or an
artefact of our search strategy. The proportion is similar
to a previous review that used the same textwords to
identify factorial studies [1]. It is interesting that cluster
trials do not have a MeSH term either but that cross-
over trials do. It is also possible that trials conceived
and conducted as a factorial design, but with results of
each intervention reported in separate publications,
would be missed.
Our focus on trials of complex interventions in com-
munity settings was partly pragmatic in order to main-
tain a manageable scope for the review, but was also
chosen to reflect the organisation of health care and the
type of research that is funded, especially in the UK.
The majority of patient contact with health care profes-
sionals in the UK National Health Service occurs in
community settings [6]. Our review is likely to be rele-
vant to a large section of research effort in the UK and
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Year of
Publication
2000-2003 2004-2009 Total
Number of
Trials
27 49 76
Heading Subheading Methodological Descriptor Frequency Percent Frequency Percent Frequency Percent
Title and
abstract
Phrase “factorial” used No 2 (7) 4 (8) 6 (8)
Yes 25 (93) 45 (92) 70 (92)
Introduction Background Rationale for factorial trial
established
Efficiency 3 (11) 4 (8) 7 (9)
Interaction 0 (0) 2 (4) 2 (3)
Both 4 (15) 3 (6) 7 (9)
Not stated 20 (74) 40 (82) 60 (79)
Methods Design Number of treatments 2 × 2 24 (89) 43 (88) 67 (88)
Other 3 (11) 6 (12) 9 (12)
Allocation Units of allocation Individual only 20 (74) 28 (57) 48 (63)
Cluster only 5 (19) 16 (33) 21 (28)
Mixed 2 (7) 5 (10) 7 (9)
Adequate description of
randomisation (generation of
sequence, execution)
No 12 (44) 24 (49) 36 (47)
Yes 15 (56) 25 (51) 40 (53)
Adequate allocation
concealment
No 1 (4) 2 (4) 3 (4)
Yes 10 (37) 21 (43) 31 (41)
Unclear 16 (59) 26 (53) 42 (55)
Sample size Sample size calculation given No 10 (37) 13 (27) 23 (30)
Yes 17 (63) 36 (73) 53 (70)
If yes, estimates based on
analysis:
At the margins 11 (65) 27 (75) 38 (71)
Interaction/
Inside the table
1 (6) 4 (11) 5 (10)
Unclear/
Inadequate
5 (29) 5 (14) 10 (19)
Statistical
methods
Analytical approach ITT 14 (52) 38 (78) 52 (68)
Not explicitly
stated
13 (48) 11 (22) 24 (32)
Primary analysis correctly
adjusted for design variables/
baseline
No 2 (7) 2 (4) 4 (5)
Yes 22 (81) 39 (80) 61 (80)
Unclear 3 (11) 8 (16) 11 (15)
For cluster allocations,
appropriate analysis used
No 2 (29) 3 (14) 5 (18)
Yes 5 (71) 17 (81) 22 (79)
Unclear 0 (0) 1 (5) 1 (4)
Results Participant
flow
Reported numbers randomly
assigned and followed up
CONSORT
diagram
15 (56) 33 (67) 48 (63)
No diagram
but adequate
text
3 (11) 2 (4) 5 (7)
Inadequate 9 (33) 14 (29) 23 (31)
Baseline
characteristics
Baseline data reported in table
for treatment groups
No 5 (19) 7 (14) 12 (16)
Yes 22 (81) 42 (86) 64 (84)
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trials may also be used to evaluate complex interven-
tions in secondary or tertiary care settings, or to evalu-
ate simple interventions in any settings. The quality of
reporting of such trials may be different to those
i n c l u d e dh e r e ,a n dt h e r e f o r ew ea d v i s ec a u t i o ni f
attempting to generalise our results to all factorial trials.
Although in most cases it was clear whether a trial
should be included in the review, we recognise that we
have applied our own definitions of complex interven-
tions and community settings, and that other investiga-
tors may have selected a different sample of trials for
analysis. Finally, our review covers the period 2000-
2009, and trials published since then may affect the
results.
Our study adds to the limited existing literature on
reporting of factorial trials. McAlister et al’s2 0 0 3r e v i e w
focussed only on trials that reported clinically important
binary outcomes [1]. The included trials were divided
into those of ischaemic heart disease and others, many
trials investigated drug treatments only, and were con-
ducted in secondary care settings with clinical patient
groups. The latest version of the CONSORT statement
[7] recognises that a substantial minority of trials use
designs other than two-arm parallel, and that while most
of the statement applies equally to all designs, there are
additional considerations for each design. The are exten-
sions to CONSORT planned to cover all other designs.
Conclusions
Reports of factorial trials of complex interventions in
community settings vary in the amount of information
they provide regarding important methodological
aspects of design and analysis. This variability supports
the extension of CONSORT guidelines to include the
reporting of factorial trials.
Additional material
Additional file 1: Search strategy (MS Word file).
Additional file 2: Characteristics of included studies (MS Excel file).
List of abbreviations
CONSORT: Consolidated Standards of Reporting Trials; ITT: Intention-to-treat;
MeSH: Medical Subject Heading; MRC: Medical Research Council; RCT:
Randomised Controlled Trial.
Table 2 Reporting of methodological aspect of included studies (Continued)
If yes, data reported: At margins 3 (14) 10 (24) 13 (20)
Inside the table 17 (77) 29 (69) 46 (72)
Both 2 (9) 3 (7) 5 (8)
Primary
analyses
Descriptive data provided at
follow up (eg mean & SD, N &
%)
No 2 (7) 7 (14) 9 (12)
Yes 25 (93) 42 (86) 67 (88)
If yes, data reported: At margins 8 (32) 13 (31) 21 (31)
Inside the table 8 (32) 18 (43) 26 (39)
Both 9 (36) 11 (26) 20 (30)
Appropriate between-group
estimate(s)
No 10 (37) 6 (12) 16 (21)
Yes 17 (63) 43 (88) 60 (79)
SE or 95% CI reported No 12 (44) 11 (22) 23 (30)
Yes 15 (56) 38 (78) 53 (70)
Interaction Results of interaction reported No 7 (26) 16 (33) 23 (30)
Yes 20 (74) 33 (67) 53 (70)
If yes, level of detail reported: No interaction
found/p-value
only
17 (85) 22 (67) 39 (74)
Interaction
estimate & SE/
CI/p-value
3 (15) 11 (33) 14 (26)
Discussion Interaction If interaction reported, was it
discussed
No 10 (50) 11 (33) 21 (40)
Yes 10 (50) 22 (67) 32 (60)
Overall
interpretation
Appropriate based on data
presented
No 4 (15) 0 (0) 4 (5)
Yes 23 (85) 49 (100) 72 (95)
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